Center Healthcare Ed. & Res. v. Internat. Cong. Joint Reconst. ( 2020 )


Menu:
  • Filed 11/30/20
    CERTIFIED FOR PUBLICATION
    COURT OF APPEAL, FOURTH APPELLATE DISTRICT
    DIVISION ONE
    STATE OF CALIFORNIA
    CENTER FOR HEALTHCARE                    D076513
    EDUCATION AND RESEARCH, INC.,
    Plaintiff, Cross-defendant and
    Respondent,                              (Super. Ct. No. 37-2017-
    00004475-CU-BC-CTL)
    v.
    INTERNATIONAL CONGRESS FOR
    JOINT RECONSTRUCTION, INC.,
    Defendant, Cross-complainant
    and Appellant;
    MARK SACARIS,
    Cross-defendant and Respondent.
    APPEAL from a judgment of the Superior Court of San Diego County,
    Kenneth J. Medel, Judge. Reversed.
    Duckor Spradling Metzger & Wynne, Scott L. Metzger and William P.
    Keith for Defendant, Cross-complainant and Appellant International
    Congress for Joint Reconstruction, Inc.
    Law Offices of Stephen B. Morris and Stephen B. Morris for Plaintiff
    and Respondent Center for Healthcare Education and Research, Inc., and
    Cross-defendant and Respondent Mark Sacaris.
    In 2009, the president of the International Congress for Joint
    Reconstruction, Inc. (ICJR) retained Mark Sacaris, part owner of the Center
    for Healthcare Education and Research, Inc. (CHE), to assist ICJR in
    producing medical education conferences on the subject of joint-
    reconstruction surgery. Their agreement was unwritten, and there was no
    discussion of the rates ICJR would be charged. Sacaris was given full control
    over ICJR’s money accounts as part of the arrangement. He was later made
    a chief operating officer (COO) and nonvoting director of ICJR.
    Sacaris provided all of the services ICJR required through CHE. He
    unilaterally set rates for these services, adding a markup on labor costs to
    create a profit for CHE and, indirectly, for himself. He used ICJR’s money
    accounts to pay CHE’s invoices without notifying ICJR’s board members of
    the amounts ICJR was being charged. Over time, and also without informing
    the board of ICJR, he increased the scope of CHE’s services to include
    developing ICJR’s websites and broadcasting live surgeries to ICJR
    conferences (despite CHE employees’ lack of necessary experience in these
    areas), and he arranged for CHE to manage symposia for pharmaceutical
    companies during ICJR conferences. Sacaris thereby created additional
    sources of profit for CHE, and indirectly for himself, but he did not disclose
    his interest in these arrangements to ICJR.
    In 2016, the board of ICJR was informed by Sacaris that ICJR had
    amassed a $2 million debt to CHE. ICJR terminated its relationship with
    Sacaris and CHE. CHE filed suit to recover amounts it claimed it was owed
    by ICJR under the agreement. ICJR filed a cross-action against Sacaris and
    2
    CHE in which it asserted they had secretly profited from their relationship
    with ICJR. ICJR sought, among other remedies, disgorgement of the profits
    CHE and Sacaris recovered in breach of their fiduciary duties, namely
    (1) their undisclosed charges for management services; (2) amounts by which
    they overcharged for web development services; (3) undisclosed profits from
    running symposia for pharmaceutical companies; and (4) undisclosed profits
    from broadcasting live surgeries.
    After a bench trial, the court issued a statement of decision in which it
    found ICJR liable to CHE for breach of contract. Although the court also
    found that CHE and Sacaris breached their fiduciary duties to ICJR in
    earning all four categories of the profits ICJR sought to disgorge, the court
    awarded ICJR recovery only as to categories two and four. The court denied
    ICJR disgorgement of the first category of profits because it found ICJR had
    failed to prove it suffered monetary damages from CHE and Sacaris’s
    undisclosed charges for management services. The court denied ICJR
    disgorgement of the third category of profits because it found ICJR failed to
    establish that running pharmaceutical symposia was an ICJR corporate
    opportunity CHE and Sacaris wrongfully usurped.
    On appeal, ICJR contends the trial court erred in determining that
    ICJR could not recover disgorgement of CHE and Sacaris’s profits from their
    undisclosed charges for management services without proof their breach of
    fiduciary duties caused ICJR to suffer monetary damages. ICJR also
    challenges the court’s determination that the symposia were not an ICJR
    corporate opportunity.
    We agree ICJR was not required to show it suffered monetary harm to
    establish a right to disgorgement of CHE and Sacaris’s profits from their
    undisclosed charges for event management services, and that the trial court
    3
    erred when it held otherwise. Because ICJR met its burden to establish a
    reasonable approximation of the amount by which CHE and Sacaris profited
    through their misconduct, the court was required to exercise its discretion to
    fashion a remedy. We will reverse the portion of the judgment affected by the
    error and remand so the trial court can determine the appropriate amount of
    the award of disgorgement. However, we reject ICJR’s claim that the court
    erred in determining that running symposia for pharmaceutical companies
    was not a corporate opportunity of ICJR.
    FACTUAL AND PROCEDURAL BACKGROUND
    A.    Factual Summary 1
    In 2008, a small number of nationally prominent orthopedic surgeons
    formed ICJR 2 for the purpose of presenting accredited continuing medical
    education conferences on the subject of joint-reconstruction surgery. It had
    become common in the years before ICJR’s formation for prosthetic device
    manufacturers to sponsor conferences, a practice that led to concerns over the
    conferences’ educational value and attracted the scrutiny of the United States
    Department of Justice under the Physician Payments Sunshine Act (42
    U.S.C. § 1320a-7h), a reporting statute that requires medical device
    manufacturers to report transfers of value to physicians. The orthopedic
    1      “We recite the facts in the manner most favorable to the judgment and
    resolve all conflicts and draw all inferences in favor of respondents.
    [Citation.] Conflicts in the evidence are noted only where pertinent to the
    issues on appeal.” (Meister v. Mensinger (2014) 
    230 Cal.App.4th 381
    , 387
    (Meister).) Because trial court’s factual findings are for the most part
    unchallenged, we derive our factual summary in large part from the court’s
    final statement of decision.
    2     ICJR was originally organized under Illinois law but was subsequently
    reorganized as a California nonprofit corporation.
    4
    surgeons who established ICJR believed the quality and stature of medical
    education conferences about joint reconstruction surgery would be improved
    if the conferences were overseen by medical experts.
    The board members of ICJR were volunteers with active medical
    practices who lacked the time and business expertise to produce medical
    conferences. Shortly after ICJR was formed, its president, Dr. William
    Norman Scott, met Sacaris, whose employment history included organizing
    educational conferences and providing management support for
    pharmaceutical companies. Sacaris and his business partner, Steve Coley,
    provided these services through two companies, Tier One Corporation (Tier
    One) and CHE. Sacaris and Coley each owned half of the shares of Tier One.
    Tier One, in turn, owned CHE. Both Tier One and CHE were for-profit
    enterprises; Sacaris and Coley profited directly from the earnings of Tier One
    and indirectly from the income of CHE. Sacaris was the president of CHE
    and managed its day-to-day operations. He was also responsible for setting
    the billable hourly rates CHE charged its clients.
    Scott hired Sacaris in June of 2009 to coordinate and manage
    conferences for ICJR and ensure all logistical details necessary for a
    successful conference took place. Both men described this as a “handshake”
    agreement; there was never a written contract between Sacaris and ICJR.
    Moreover, Sacaris never provided, and Scott never requested, any
    information about the rates ICJR would be charged for his services. 3
    3     The record contains very little information about the composition of
    ICJR’s board, its corporate bylaws or adherence to corporate formalities.
    ICJR’s board members would convene each year while attending another
    annual medical event. Sacaris claimed he provided financial updates during
    these meetings, although the record before us contains only two such
    updates, one relating to a single conference in Australia in 2014 and another
    covering the first eight months of 2013; neither mentions CHE. Sacaris also
    5
    From the beginning, Sacaris provided all of ICJR’s management service
    needs through CHE. At trial, the parties disputed whether ICJR had agreed
    to or was even aware of CHE’s participation. Sacaris testified that he viewed
    himself as an agent of CHE, and that in his mind, by retaining him, ICJR
    had also retained CHE. While he claimed to have disclosed CHE’s existence
    during conversations with Scott, his communications with the board were
    less than transparent. In two written updates sent to the full board in
    October 2013 and April 2014, he characterized CHE employees as being part
    of ICJR’s organizational structure. It was not until July 2014 that he first
    notified the full board of CHE’s existence.
    Scott testified he was aware of CHE from the start and associated it
    with Sacaris, but at trial he could not recall what he had understood about
    CHE’s role in the arrangement with ICJR at the time he retained Sacaris’s
    services. He also testified that he was not made aware that certain
    individuals Sacaris had hired to work for ICJR were actually employees of
    CHE. The trial court found, “based on [] Scott’s awareness of CHE, coupled
    with his failure to recall what he was told about CHE’s involvement,” that
    “ICJR did not prove that Dr. Scott was ignorant or unaware of CHE’s role in
    the management of ICJR throughout the chronology.” The parties do not
    challenge this finding.
    As part of the arrangement with ICJR, Sacaris was given full control
    over ICJR’s money accounts, including its checking account, for payment of
    testified that he spoke to Scott every month, to ICJR’s treasurer two or three
    times per year, to ICJR’s secretary once a year, and to another ICJR board
    member two or three times per year. The record is silent with regard to the
    authority each of these individuals possessed on behalf of ICJR. However,
    Scott appears to have exercised the greatest degree of oversight and control
    over Sacaris’s activities.
    6
    all invoices and expenses associated with ICJR’s conferences. As a result,
    Sacaris had the ability to prepare and adjust his own bill as manager of CHE,
    and then approve payment of CHE’s bill on behalf of ICJR, without the
    knowledge or approval of ICJR’s board of directors, a circumstance the court
    found “created an obvious conflict of interest.”
    Sacaris and CHE organized and ran conferences for ICJR from 2009
    until 2016. As ICJR proposed conferences to Sacaris, Sacaris dispatched up
    to 11 CHE employees to do the work necessary to arrange them.
    Sacaris profited by funneling the services provided to ICJR through
    CHE. CHE employees, including Sacaris, billed for their services by the
    hour. As conferences were completed, Yana Drozdova, CHE’s accountant,
    would prepare internal worksheets for Sacaris that summarized the hourly
    rates, and number of hours billed, for every CHE employee. Sacaris, on
    behalf of CHE, would then increase the employees’ hourly rates by between
    17 percent and 20 percent to reimburse CHE for its overhead expenses, and
    he would add an additional markup of up to 80 percent of the employees’
    hourly rates to create a profit for CHE, and indirectly, for himself. 4 Sacaris
    did not disclose to ICJR that he was profiting by marking up its labor costs.
    4     In 2013, this markup process raised CHE employees’ bottom-line
    hourly rates by 20 percent for CHE’s overhead, and an additional 80 percent
    for CHE’s profit margin. In 2014, the markups raised employees’ hourly
    rates by 17 percent for CHE’s overhead, and 70 percent for its profit margin.
    In 2015, Sacaris marked up employees’ hourly rates (including his own) by 17
    percent for overhead, and between 30 percent and 55 percent for CHE’s profit
    margin; and in 2016, the rates were marked up by 17 percent for overhead
    and 55 percent for profit margin. In 2013, CHE billed over 9,000 hours to
    ICJR; in 2014, CHE’s hours for ICJR exceeded 6,800; in 2015, CHE billed
    over 17,000 hours to ICJR; and in 2016, CHE billed over 6,300 hours for
    services provided to ICJR.
    7
    Once Sacaris determined the amounts to be billed to ICJR, Drozdova
    would create an invoice. The resulting invoices were transmitted to no one
    other than Sacaris. Sacaris would then approve payment on behalf of ICJR
    and would direct Drozdova to issue payment to CHE out of ICJR’s checking
    account. In the trial court’s words, ICJR was thus kept “completely blind to
    the amounts billed by CHE for services and expenses as no invoice or billing
    information was ever submitted to any of the ICJR Board of Directors,
    including its president and treasurer.”
    Over time, Sacaris and CHE expanded the scope of the services they
    were providing to ICJR. Sacaris assigned CHE the work of developing and
    maintaining ICJR’s websites, even though CHE employees had little or no
    experience in website development, a fact Sacaris did not disclose to ICJR.
    As a result, ICJR was overbilled for website development services and was
    left without a working website.
    One feature of ICJR conferences was the live broadcast of joint
    replacement surgeries performed offsite at remote locations. Sacaris initially
    hired outside professionals to produce these broadcasts. Later, Sacaris
    convinced his business partner, Coley, to secretly form a new company called
    Live Surgery to perform the professional audio-visual work Sacaris had
    previously outsourced. Live Surgery was owned by Tier One, which meant
    Live Surgery’s profits were divided by Sacaris and Coley. After Live
    Surgery’s formation, Sacaris began assigning all of ICJR’s broadcasting needs
    to Live Surgery, never informing ICJR of his interest in the company. The
    quality of Live Surgery’s broadcasts was poor, which led conference attendees
    to complain and harmed ICJR’s reputation.
    Pharmaceutical companies approached Sacaris about the possibility of
    conducting brief symposia to promote their medications at opportune times
    8
    during ICJR conferences. Sacaris, on behalf of ICJR, granted permission for
    the symposia conditioned on the companies paying substantial honoraria to
    ICJR. However, without informing ICJR, Sacaris also arranged to have CHE
    run the symposia for the pharmaceutical companies, creating an additional
    source of profit for himself.
    In 2013, Sacaris was made a chief operating officer of ICJR and a
    nonvoting member of its board of directors. The change in Sacaris’s official
    role at ICJR had no corresponding effect on his billing practices. He
    continued to invoice ICJR, and pay CHE, without notifying anyone at ICJR
    other than himself.
    At times, there were insufficient funds in ICJR’s account to pay CHE’s
    invoices. When this occurred, CHE would advance the invoiced amounts with
    the expectation of being reimbursed by ICJR when its account was
    replenished. As time passed, ICJR’s debt to CHE grew. Despite grossing $20
    million over the course of its relationship with Sacaris, ICJR began to operate
    at a loss.
    In February of 2016, Sacaris informed the board that ICJR had
    amassed a debt to CHE of $2 million and demanded payment. Not long after,
    a CHE employee shared concerns about CHE’s billing practices with
    members of the board. 5 In the trial court’s words, both pieces of information
    came as “a shock to Dr. Scott and the Board and led ICJR to . . . discover:
    (1) the details of Mr. Sacaris’s and CHE’s billing practices vis-[a]-vis ICJR,
    (2) that pharmaceutical companies had hired Mr. Sacaris and CHE to
    conduct and manage symposia held at ICJR conferences, and (3) that
    5     The employee’s concerns included that he and other CHE employees
    were required to bill ICJR when they took time off, meaning ICJR was billed
    for hours that CHE employees did not actually work.
    9
    Mr. Sacaris and Mr. Cole[y,] through their company[,] Tier One[,] had formed
    a new company called Live Surgery to replace previous companies that had
    broadcast orthopedic surgeries from a remote location to ICJR conferences.”
    ICJR investigated CHE’s billing practices and terminated its
    relationship with Sacaris and CHE in January 2017 without paying the
    demand. It retained a new firm, a nonprofit entity called the Foundation for
    Orthopedic Research and Education (FORE), to replace CHE.
    B.    Procedural Background
    On February 3, 2017, CHE filed a form complaint against ICJR that
    stated a single cause of action for breach of contract and sought $2,400,000 in
    damages. ICJR, in turn, filed a cross-complaint against both CHE and
    Sacaris, alleging that Sacaris, through CHE, had secretly profited from
    Sacaris’s relationship with ICJR. ICJR asserted causes of action against
    Sacaris and CHE for breach of fiduciary duty, fraud, negligence, conversion,
    violation of Business and Professions Code section 17200, constructive trust,
    and accounting. In its prayer for relief, ICJR sought to recover damages as
    well as “disgorgement and restitution of all profits and gains obtained by
    [CHE and Sacaris’s] illegal and improper acts and omissions,” among other
    remedies.
    1.    Trial
    The action and cross-action were tried in a four-day bench trial in
    January 2019. At trial, ICJR offered little opposition to CHE’s breach of
    contract claim apart from noting that CHE appeared to have duplicated an
    item of its alleged damages (hotel costs of $133,799).
    Instead, ICJR focused on offsetting CHE’s damages by recovering
    under its cross-claims. ICJR identified four ways in which CHE and Sacaris
    had allegedly breached their duties to ICJR under the cross-claims and
    10
    sought disgorgement of the undisclosed profits recovered through each form
    of misconduct. These four categories of wrongdoing and associated relief
    were: (1) the profits CHE and Sacaris earned from the management services
    provided to ICJR, on the theory that their failure to disclose the amounts
    they were charging or compensating themselves for their services breached
    their fiduciary duties to ICJR; (2) the amount by which CHE and Sacaris
    overbilled ICJR for managing and developing ICJR’s websites, without
    disclosing their fees or their employees’ lack of necessary website
    development experience; (3) the amount by which CHE and Sacaris profited
    by assisting pharmaceutical companies with mid-conference symposia,
    without disclosing this arrangement to ICJR; and (4) the amount by which
    Sacaris profited by running ICJR’s live surgery broadcasts through Live
    Surgery, while actively concealing his interest in Live Surgery from ICJR.
    ICJR designated Robert Taylor, a certified public accountant and
    business valuation expert, to review CHE’s financial records and opine as to
    the dollar value of each of these four categories of recovery. Taylor testified
    that between 2013 and 2016, 6 CHE (and indirectly, Sacaris) had (1) created
    profits of $1,430,260 for the event management services CHE provided to
    ICJR by marking up their hourly labor rates; (2) overbilled ICJR by $800,000
    for managing and developing ICJR’s websites (a calculation also supported by
    the opinion of a website development expert); (3) earned net profits of
    6     ICJR sought to recover amounts CHE and Sacaris earned during the
    four-year period preceding the filing of its cross-complaint, which corresponds
    to the four-year statute of limitations that applies to a cause of action for
    breach of fiduciary duty. (Code of Civ. Proc., § 343; Manok v. Fishman (1973)
    
    31 Cal.App.3d 208
    , 213.)
    11
    $608,027 for assisting pharmaceutical companies with symposia during ICJR
    conferences; and (4) profited by $73,310 from the operations of Live Surgery.
    CHE and Sacaris did not dispute the accuracy of these figures.
    However, Sacaris testified that CHE’s rates were reasonable, and Sacaris and
    Drozdova each testified that the rates CHE charged ICJR were lower than
    the rates it charged other clients. These assertions were unaccompanied by
    supporting documents or other corroborating evidence.
    The parties filed requests for a statement of decision. On May 9, 2019,
    the court issued a tentative statement of decision to which ICJR objected,
    including on the grounds it now asserts on appeal. On May 31, 2019, the
    court held a hearing on ICJR’s objections.
    2.    Statement of Decision
    On June 21, 2019, the trial court issued its final statement of decision,
    which was substantially unchanged from its tentative statement of decision.
    The court found in favor of CHE on its breach of contract claim and awarded
    $2,299,259.42 in damages, representing the amount requested by CHE minus
    the duplicative item contested by ICJR. The court then considered whether
    ICJR had proven its cross-claims by separately analyzing the factual and
    legal merits of each of its four theories of wrongdoing and associated
    remedies.
    (i)   Income Received Directly by CHE and Indirectly by
    Sacaris for Management Services Provided to ICJR
    The trial court denied ICJR recovery under its first theory of
    wrongdoing. Although it found that CHE and Sacaris were managers, and
    thus fiduciaries, of ICJR throughout their relationship with ICJR, that
    Sacaris’s fiduciary duties were heightened once he became a COO and
    director of ICJR, and that CHE and Sacaris breached their fiduciary duties
    throughout their relationship by failing to disclose any information about the
    12
    amounts they were charging ICJR, and compensating themselves, for their
    services, it also found that ICJR failed to prove it was overcharged and thus
    suffered economic damages from the breach.
    (ii)    Web Development
    The court found CHE and Sacaris breached their fiduciary duties by
    failing to disclose the amounts they were charging ICJR for website work and
    their lack of necessary experience in web development. The court awarded
    ICJR $800,000 on this claim, finding ICJR succeeded in proving it was
    overbilled by this amount for website development work.
    (iii)   Pharmaceutical Symposia
    The court denied ICJR recovery based on CHE’s and Sacaris’s failure to
    disclose that they were managing, and profiting from, the pharmaceutical
    company symposia. The court found that while Sacaris and CHE breached
    their fiduciary duties by failing to disclose to ICJR that they had agreed to
    manage the symposia, that ICJR suffered no harm from the nondisclosures
    since organizing symposia for pharmaceutical companies was not an
    opportunity ICJR would have considered for itself.
    (iv)    Live Surgery
    The court found Sacaris and CHE breached their fiduciary duties and
    defrauded ICJR by actively concealing Sacaris’s interest in Live Surgery, of
    which he was a de facto owner through his half ownership of Tier One. It
    awarded ICJR $73,310 for this misconduct, finding this was the amount by
    which Sacaris had profited through Live Surgery.
    3.    Judgment
    On August 29, 2019, the court entered judgment (1) in favor of CHE on
    CHE’s cause of action for breach of contract in the amount of $2,299,259.42;
    (2) in favor of ICJR and against Sacaris and CHE as to ICJR’s cross-claim for
    13
    breach of fiduciary duty (first cause of action) relating to website overbilling,
    in the amount of $800,000; (3) in favor of ICJR and against Sacaris and CHE
    as to ICJR’s cross-claims for breach of fiduciary duty and fraud (first through
    third causes of action), pertaining to amounts billed through Live Surgery, in
    the amount of $73,310.00; (4) in favor of CHE and Sacaris and against ICJR
    as to ICJR’s cross-claims for breach of fiduciary duty and fraud (first through
    third causes of action) based on ICJR’s remaining theories of recovery;
    (5) dismissing ICJR’s fourth cause of action for negligence; and (6) in favor of
    CHE and Sacaris and against ICJR on the remainder of the causes of action
    asserted in ICJR’s cross-complaint. The court awarded prejudgment interest
    in amounts stipulated by the parties and declared that neither side was the
    prevailing party as it pertained to costs.
    DISCUSSION
    A.    The Trial Court Erred in Finding ICJR Failed to Establish a
    Right to Disgorgement of the Profits CHE and Sacaris Recovered
    in Breach of Their Duties as Fiduciaries of ICJR
    1.     Additional Background
    The trial court’s statement of decision thoroughly details its factual and
    legal findings relating to ICJR’s cross-claim for disgorgement of the profits
    CHE and Sacaris recovered through their practice of charging and
    compensating themselves for management services without full disclosure to
    ICJR. Rather than summarize the court’s comprehensive findings, we set
    forth in full the relevant portions of the court’s decision.
    “The Court finds that Mr. Sacaris and CHE had fiduciary duties to
    ICJR from the outset, both as the manager of ICJR’s business and later in
    Mr. Sacaris’[s] role as both ICJR’s [COO] and [director]. [Citations.] Both
    Mr. Sacaris and CHE breached their fiduciary duties from the beginning and
    throughout the chronology by never disclosing to the Board of Directors,
    14
    including President[] Dr. Scott, the fundamental, bottom-line, hourly billing
    rates CHE would and did charge ICJR for its services. Such information
    should have included Mr. Sacaris’s billing rate, the billing rate of any other
    CHE employees who might work on these conferences, the periodicity of
    billing, a bottom line charge for overhead, and perhaps a rough calculation of
    anticipated expenses for conferences in general.
    “CHE (Sacaris) was not a common independent contractor detached
    from ICJR with no fiduciary responsibilities. Quite the contrary, Mr. Sacaris
    had exclusive control of ICJR’s finances, exclusive even to ICJR. [Citations.]
    Mr. Sacaris should have recognized the obvious conflict of interest of both
    billing for CHE and approving and paying his own bill [on] behalf of ICJR.
    CHE (Sacaris) should have promptly and regularly provided the ICJR Board
    with a summary of all CHE invoices and expenses, including the hourly
    charges of all CHE employees and overhead charges. ICJR should also have
    received more frequent, perhaps quarterly reports on its financial status.
    This fiduciary duty was heightened, not abrogated, when Mr. Sacaris became
    the [COO] and a Non-Voting member of the Board of Directors because in his
    role as COO the conflict of interest persisted. [¶] . . . [¶]
    “Nonetheless, the [c]ourt finds that Mr. Sacaris and CHE as fiduciaries
    were not required to disclose to ICJR exactly how CHE computed or arrived
    at the bottom line hourly rate of either Mr. Sacaris or CHE employees. CHE
    was not required to tell ICJR about the 40 [percent] to 80 [percent] mark-up
    on CHE’s employee hours and the 17-20 [percent] ‘overhead’ mark-up applied
    to employee hours billed. Employing common sense and experience, the
    Court believes that few, if any, service providers provide their clients or
    customers precise information on how exactly they profit by disclosing details
    about worker salary, overhead, or product mark-up. Even [fiduciaries] with
    15
    heightened duties of care, such as investment advisors, and at times,
    accountants and attorneys do not commonly reveal to their clients exactly
    how they arrived at their fee structure, their measure of profits, or how
    overhead charges are calculated.
    “Even absent those details, had CHE provided the bottom line
    employee hourly billing rate, plus any other incidental charges (such as the
    amount charged for overhead) that augmented the bottom line, as well as an
    estimate of conference expenses, and thereafter provided routine invoices to
    ICJR, those measures would have triggered ICJR’s obligation to scrutinize
    and investigate any irregularity in the billing and take . . . appropriate
    action. Yes, ICJR behaved throughout the chronology as if unconcerned
    about these details, but that did not obviate CHE’s (Sacaris’s) fundamental
    fiduciary duty of disclosure.
    “As to damages, the [c]ourt heard no evidence that the management
    services (other than web development) provided by CHE or ICJR and the
    expenses charged, exceeded what other like service providers would have
    charged ICJR. Mr. Jason Heath, a former CHE employee[,] testified as to his
    concerns about the hourly employee mark-ups, concerns that motivated him
    to warn ICJR of possible overbilling. But Ms. Drozdova, CHE’s accountant,
    testified that all other CHE clients were charged a higher billing rate.
    Mr. Sacaris testified that his services overall were provided at or below
    market rate. ICJR presented no expert testimony that would suggest that
    CHE’s billing was extraordinary, except for the web development.
    Consequently, ICJR did not prove that it suffered any harm or loss.
    [¶] . . . [¶]
    “Without harm or loss, ascertainable or incalculable, without secret
    profit or tortious gain, no remedy is available for the breach of fiduciary duty.
    16
    [Citation.] Neither damages for unjust enrichment nor disgorgement are
    appropriate to this claimed breach of fiduciary duty. There is no
    proof . . . that the failure to disclose caused harm, an element of . . . breach of
    fiduciary duty . . . .”
    2.     Contentions on Appeal
    ICJR contends that once the trial court found CHE and Sacaris
    breached their fiduciary duties to ICJR, it erred as a matter of law when it
    held ICJR was required to present evidence it suffered monetary harm or loss
    from the breach in order to recover. 7 ICJR argues that when a principal
    seeks disgorgement of a fiduciary’s secret profits, the appropriate measure of
    the damages resulting from the breach of fiduciary duties is the amount of
    the fiduciary’s wrongfully-acquired profits. ICJR maintains that once it
    established that CHE and Sacaris breached their fiduciary duties, and the
    amount by which CHE and Sacaris directly and indirectly profited from the
    breach, under Meister, supra, 
    230 Cal.App.4th 381
    , the court was required to
    fashion a remedy.
    CHE and Sacaris argue the court’s decision should be reviewed for an
    abuse of discretion. They also argue the court correctly determined their
    profits were not “secret” and therefore not subject to disgorgement.
    7      As we have noted, ICJR only challenges the trial court’s finding that it
    failed to establish a right to recovery under its cross-claim for breach of
    fiduciary duties. ICJR does not dispute the court’s determination that CHE
    and Sacaris were not liable under the other causes of action in the cross-
    complaint. We limit our review accordingly. (See Tiernan v. Trustees of Cal.
    State University & Colleges (1982) 
    33 Cal.3d 211
    , 216, fn. 4 [party deemed to
    have abandoned a position asserted in the trial court but not renewed on
    appeal]; accord Eck v. City of Los Angeles (2019) 
    41 Cal.App.5th 141
    , 146.
    17
    3.     Standard of Review
    The trial court’s selection of the rule governing ICJR’s cross-claim for
    breach of fiduciary duties raises a question of law that we review
    independently. (Kellogg v. Garcia (2002) 
    102 Cal.App.4th 796
    , 802.) ICJR’s
    appeal additionally challenges the court’s determination that it failed to
    sustain its burden of proof on an element of its cross-claim. “ ‘When the trier
    of fact has expressly or implicitly concluded that the party with the burden of
    proof failed to carry that burden and that party appeals, it is somewhat
    misleading to characterize the failure-of-proof issue as whether substantial
    evidence supports the judgment . . . . Thus, where the issue on appeal turns
    on a failure of proof at trial, the question for a reviewing court becomes
    whether the evidence compels a finding in favor of the appellant as a matter
    of law. [Citations.] Specifically, the question becomes whether the
    appellant’s evidence was (1) “uncontradicted and unimpeached” and (2) “of
    such a character and weight as to leave no room for a judicial determination
    that it was insufficient to support a finding.” ’ ” (Meister, supra, 230
    Cal.App.4th at p. 395, quoting Shaw v. County of Santa Cruz (2008) 
    170 Cal.App.4th 229
    , 279.)
    4.     Analysis
    We conclude that the trial court erred when it held ICJR could not
    recover on its cross-claim for breach of fiduciary duties in the absence of
    evidence it suffered economic harm from the breach. Because ICJR was
    seeking the equitable remedy of disgorgement of secret profits, not the legal
    remedy of compensatory damages, ICJR was not required to show it suffered
    pecuniary harm to establish a right to disgorgement of the profits CHE and
    Sacaris earned from their misconduct.
    18
    A claimant pursuing a cause of action for breach of fiduciary duties
    “ha[s] the right to elect the kind of relief they seek.” (Hicks v. Clayton (1977)
    
    67 Cal.App.3d 251
    , 265 (Hicks).) The available relief includes damages or
    any of a “variety of equitable remedies,” including disgorgement of profits.
    (Meister, supra, 230 Cal.App.4th at p. 396; Hicks, at pp. 264-265; Haurat v.
    Superior Court (1966) 
    241 Cal.App.2d 330
    , 334 [“The principal has a cause of
    action either for a breach of contract or for a tort as a remedy for damage
    caused by the violation of any duty of loyalty on the part of an agent. He may
    also charge the agent with anything the agent receives as the result of a
    violation of duty.”].)
    The aim of these equitable remedies is to enforce the high standards of
    conduct to which a fiduciary must be held. “The animating principle of a
    fiduciary’s duties to his charges is unfaltering loyalty and honesty. ‘Many
    forms of conduct permissible in a workaday world for those acting at arm’s
    length, are forbidden to those bound by fiduciary ties. A trustee is held to
    something stricter than the morals of the market place. Not honesty alone,
    but the punctilio of an honor the most sensitive, is then the standard of
    behavior. As to this there has developed a tradition that is unbending and
    inveterate. Uncompromising rigidity has been the attitude of courts of equity
    when petitioned to undermine the rule of undivided loyalty by the
    “disintegrating erosion” of particular exceptions [citation]. Only thus has the
    level of conduct for fiduciaries been kept at a level higher than that trodden
    by the crowd.’ ” (Feresi v. The Livery, LLC (2014) 
    232 Cal.App.4th 419
    , 425-
    426 (Feresi), quoting Meinhard v. Salmon (1928) 
    249 N.Y. 458
    , 464.) “ ‘When
    agents and others, acting in a fiduciary capacity, understand that these rules
    will be rigidly enforced, even without proof of actual fraud, the honest will
    keep clear of all dealings falling within their prohibition, and those
    19
    dishonestly inclined will conclude that it is useless to exercise their wits in
    contrivances to evade it.’ ” (Farmers’ & Merchants’ Bank of Los Angeles v.
    Downey (1879) 
    53 Cal. 466
    , 468-469, quoting Bain v. Brown (1874) 
    56 N.Y. 285
    , 288-289.)
    Notably, “[d]isgorgement as a remedy is broader than restitution or
    restoration of what the plaintiff lost.” (Meister, supra, 230 Cal.App.4th at
    p. 398.) “ ‘The emphasis is on the wrongdoer’s enrichment, not the victim’s
    loss. In particular, a person acting in conscious disregard of the rights of
    another should be required to disgorge all profit because disgorgement both
    benefits the injured parties and deters the perpetrator from committing the
    same unlawful actions again. [Citations.]’ ” (Id. at pp. 398-399, quoting
    County of San Bernardino v. Walsh (2007) 
    158 Cal.App.4th 533
    , 542-543
    (County of San Bernardino).)
    Thus, while “[t]he elements of a cause of action for breach of fiduciary
    duty are the existence of a fiduciary relationship, its breach, and damage
    proximately caused by that breach” (Meister, supra, 230 Cal.App.4th at
    p. 395), a principal seeking disgorgement of a fiduciary’s wrongful gains is
    not required to prove it suffered economic damage from the breach in order to
    recover. “Where a person profits from transactions conducted by him as a
    fiduciary, the proper measure of damages is full disgorgement of any secret
    profit made by the fiduciary regardless of whether the principal suffers any
    damage.” (County of San Bernardino, supra, 158 Cal.App.4th at p. 543.)
    “ ‘[W]here an agent is guilty of concealment or nondisclosure of material facts
    relating to the subject matter of the agency, he forfeits his right to
    compensation. It is not necessary that actual injury to the principal be shown’
    20
    (emphasis added). [Citation.]” (J.C. Peacock, Inc. v. Hasko (1961) 
    196 Cal.App.2d 353
    , 358 (J.C. Peacock, Inc.).) 8
    Instead, where an aggrieved principal seeks disgorgement as a remedy
    for a breach of fiduciary duties, “ ‘[t]he party seeking disgorgement “has the
    burden of producing evidence permitting at least a reasonable approximation
    of the amount of the wrongful gain. . . .” ’ ” (Meister, supra, 230 Cal.App.4th
    at p. 399, quoting Uzyel v. Kadisha (2010) 
    188 Cal.App.4th 866
    , 894 (Uzyel).)
    “ ‘[P]rofit includes any form of use value, proceeds, or consequential gains
    [citation] that is identifiable and measurable and not unduly remote.’ ”
    (Meister, at p. 399, quoting Rest.3d Restitution and Unjust Enrichment, § 51,
    subd. (5)(a).) The burden then shifts to the fiduciary to “present evidence of
    costs, expenses, and other deductions to show the actual or net benefit the
    [fiduciary] received.” (Meister, at p. 399.) “[T]he ‘ “residual risk of
    uncertainty in calculating net profit is assigned to the wrongdoer.” ’ ” (Ibid.,
    quoting Uzyel, at p. 894.)
    An action for disgorgement of a fiduciary’s wrongful gains is sometimes
    referred to as seeking recovery of “secret profits.” “Secret profits” consist of
    all benefits an agent acquires from the agency in excess of the agent’s agreed
    compensation. (Savage v. Mayer (1949) 
    33 Cal.2d 548
    , 551; see Bardis v.
    Oates (2004) 
    119 Cal.App.4th 1
    , 11, 13 (Bardis) [partner violated partnership
    8       The Restatement Third of Agency further explains that “[t]he
    requirement that a principal establish damage is inconsistent with a basic
    premise of remedies available for breach of fiduciary duty, which is that a
    principal need not establish harm resulting from an agent’s breach to require
    the agent to account. The requirement may also tempt an agent to undertake
    conduct that breaches the agent’s fiduciary duty in the hope that no harm
    will befall the principal or that, if it does, the principal will be unable to
    establish it or unable or unwilling to expend the necessary resources required
    to litigate the question.” (Rest.3d Agency, § 8.01, com. d(2).)
    21
    agreement and fiduciary duties by using a “dummy middleman” company to
    secretly mark up partnership invoices and collect the resulting profits].)
    Breach of the duties of loyalty and full disclosure may justify forfeiture of all
    income. (J.C. Peacock, Inc., supra, 196 Cal.App.2d at p. 358.) “An agent’s
    breach of fiduciary duty is a basis on which the agent may be required to
    forfeit commissions and other compensation paid or payable to the agent
    during the period of the agent’s disloyalty.” (Rest.3d Agency § 8.01, subd.
    (d)(2).)
    Here, there was no agreement as to the amount of Sacaris’s (or CHE’s)
    compensation. Sacaris, on behalf of CHE, nevertheless proceeded to set
    CHE’s rates, and compensate CHE, without adequate disclosure to the board
    of ICJR. This course of conduct breached the duties of loyalty and full
    disclosure. As the Restatement Third of Agency explains, “[a]n agent . . . is
    not free to exploit gaps or arguable ambiguities in the principal’s instructions
    to further the agent’s self-interest, or the interest of another, when the
    agent’s interpretation does not serve the principal’s purposes or interests
    known to the agent. This rule for interpretation by agents facilitates and
    simplifies principals’ exercise of the right of control because a principal, in
    granting authority or issuing instructions to an agent, does not bear the risk
    that the agent will exploit gaps or ambiguities in the principal’s instructions.”
    (Rest.3d Agency, § 1.01, com. e.) Moreover, “[i]f an agent acts on behalf of the
    principal in a transaction with the agent, the agent’s duty to act loyally in the
    principal’s interest conflicts with the agent’s self-interest. Even if the agent’s
    divided loyalty does not result in demonstrable harm to the principal, the
    agent has breached the agent’s duty of undivided loyalty.” (Id., § 8.03, com.
    b; see Trafton v. Youngblood (1968) 
    69 Cal.2d 17
    , 26-28 (Trafton) [attorney
    breached fiduciary duties and gained advantage over client by unilaterally
    22
    determining his fee and withdrawing funds held in trust to satisfy fee
    without first notifying client].) By breaching their fiduciary duties and
    compensating themselves from ICJR’s accounts without adequate disclosure
    or board approval, Sacaris, and thus CHE, risked that some or all of their
    compensation would be disgorged.
    In concluding that ICJR failed to establish a right to recovery, the trial
    court thus erred in two respects. First, having found that CHE and Sacaris
    were fiduciaries of ICJR and that they breached their fiduciary duties
    throughout their relationship with ICJR, the court erred when it held ICJR
    could not recover for the breach without evidence CHE’s and Sacaris’s
    misconduct resulted in it being overcharged for their services. Because ICJR
    was pursuing the equitable remedy of disgorgement and not the legal remedy
    of damages, it was not required to prove it suffered such pecuniary damage or
    loss in order to recover. (Meister, supra, 230 Cal.App.4th at p. 396 [damages
    are “the quantification of detriment suffered by a party”].) Instead, ICJR had
    the burden to prove a “reasonable approximation” of the benefit CHE and
    Sacaris gained from the breach of their fiduciary duties, a burden which, as
    we discuss post, it sustained.
    Second, in concluding that CHE and Sacaris did not recover “secret
    profits” through the breach of their fiduciary duties, the trial court
    misperceived the concept of “secret profits.” The “secret profits” subject to
    disgorgement are simply the fiduciary’s undisclosed earnings. “There can be
    no secret profits allowed to the trustee, inasmuch as it owes to the beneficiary
    the duty of fullest disclosure of all material facts.” (Van de Kamp v. Bank of
    America (1988) 
    204 Cal.App.3d 819
    , 835; see Roberts v. Lomanto (2003) 
    112 Cal.App.4th 1553
    , 1570 [broker’s $1.2 million assignment fee was “a form of
    compensation to her that was not disclosed to [her client] until after the sale”
    23
    and thus was “by definition a secret profit”]; Crogan v. Metz (1956) 
    47 Cal.2d 398
    , 405 [holding that where “the whole transaction was tainted by a breach
    of duty” the entirety of the resulting profits “may be recovered as secret
    profits from those who jointly received it while acting in concert in a fiduciary
    relationship”].)
    The court’s conclusion that CHE and Sacaris recovered no “secret
    profits” from the breach of their fiduciary duties appeared to be derived from
    its earlier determination that since professionals generally do not share the
    calculations underlying their hourly rates, CHE and Sacaris were likewise
    not required to inform ICJR that the rates they charged ICJR for their labor
    included profit markups of 40 percent to 80 percent and overhead markups of
    17 percent to 20 percent. Although on appeal ICJR challenges the court’s
    analogy to the billing practices of other professionals, this misses the point.
    Whether or not CHE and Sacaris were required to disclose their profit
    markups directly by openly sharing the calculations underlying their hourly
    rates, the court’s findings of breach reflected a determination that they were
    nevertheless required to disclose the markups indirectly by disclosing their
    hourly rates to ICJR as well as the overall amounts they were charging, and
    compensating themselves, for their services. It was the failure to disclose any
    of this bottom-line information that made their resulting profits “secret” for
    purposes of the rules governing disgorgement.
    CHE and Sacaris characterize certain comments made by the trial
    court during a posttrial hearing as reflecting a finding that Scott, and thus
    ICJR, were generally aware Sacaris and CHE were profiting from their
    services. However, the findings subject to appellate review are those set forth
    in court’s statement of decision (Thompson v. Asimos (2016) 
    6 Cal.App.5th 970
    , 981-982), and the trial court’s statement of decision contains no such
    24
    finding. Instead, the court expressly found in its statement of decision that
    CHE and Sacaris breached their duties by failing to disclose any information
    about the amount of their charges, which encompassed their profits.
    Moreover, even if the court had made such a finding, ICJR’s assumption that
    CHE and Sacaris were working for a profit did not excuse their failure to
    disclose their actual fees and charges before compensating themselves from
    ICJR’s accounts. (Trafton, supra, 69 Cal.2d at pp. 26-28.) 9
    5.     Conclusion
    Once ICJR demonstrated that CHE and Sacaris breached their
    fiduciary duties, to establish a right to recover in disgorgement, ICJR had the
    burden of producing evidence “ ‘permitting at least a reasonable
    approximation’ ” of their wrongful gain. (Meister, supra, 230 Cal.App.4th at
    p. 399.) “[T]he unjust enrichment . . . of a defaulting fiduciary without regard
    to notice or fault, is the net profit attributable to the underlying wrong.”
    (Rest.3d Restitution and Unjust Enrichment, supra, § 51, subd. (4), italics
    added.) “This profit-based measure of unjust enrichment determines
    9      Several days before oral argument, counsel for CHE and Sacaris
    submitted a letter under California Rules of Court, rule 8.254(a) and (b),
    notifying this court of counsel’s intention to cite to DeGarmo v. Goldman
    (1942) 
    19 Cal.2d 755
    , 764 (DeGarmo) during his oral presentation. We reject
    counsel’s request to rely on DeGarmo because as a case published in 1942, it
    falls outside the scope of rule 8.254, which only allows for citations to “new
    authority.” And even if we were to consider DeGarmo, it would not alter our
    decision. The cited portion of the DeGarmo opinion relates to the equitable
    defense of unclean hands, yet there is no indication CHE or Sacaris pursued
    an unclean hands defense at trial or sought a ruling on the defense in the
    trial court’s statement of decision. Accordingly, the defense is not available
    to them on appeal. (Bardis, supra, 119 Cal.App.4th at p. 13, fn. 6 [“New
    theories of defense, just like new theories of liability, may not be asserted for
    the first time on appeal.”]; Moriarty v. Carlson (1960) 
    184 Cal.App.2d 51
    , 57-
    58.)
    25
    recoveries against conscious wrongdoers and defaulting fiduciaries. Recovery
    so measured may potentially exceed any loss to the claimant.” (Id., com. a.)
    Moreover, “ ‘[p]rofit includes any form of use value, proceeds, or
    consequential gains [citation] that is identifiable and measurable and not
    unduly remote.’ ” (Meister, supra, 230 Cal.App.4th at p. 399, quoting Rest.3d
    Restitution and Unjust Enrichment, § 51, subd. (5)(a).) ICJR submitted
    uncontradicted evidence in form of its expert accountant’s testimony
    establishing that CHE’s and Sacaris’s undisclosed charges for management
    services earned them $1,430,260 in profits from ICJR between 2013 and
    2016. 10 Under the foregoing rules, this evidence was sufficient to meet
    ICJR’s burden of proof and establish a right to a recovery.
    “ ‘Judicial discretion to grant relief becomes judicial duty to grant it
    under some circumstances, and the grace which equity should bestow then
    becomes a matter of right . . . .’ ” (Meister, supra, 230 Cal.App.4th at p. 396,
    quoting Hicks, supra, 67 Cal.App.3d at p. 265.) Having met its burden of
    proof, ICJR was entitled to have the trial court fashion a remedy. The court
    never reached this point because it erroneously concluded ICJR had failed to
    establish a right to recovery.
    ICJR requests that rather than remand to the trial court for further
    proceedings, that we modify the judgment to award ICJR $1,430,260 on this
    claim and affirm the modified judgment. “Whenever an appellate court may
    make a final determination of the rights of the parties from the record on
    appeal, it may, in order to avoid subjecting the parties to any further delay or
    expense, modify the judgment and affirm it, rather than remand for a new
    determination.” (Sagadin v. Ripper (1985) 
    175 Cal.App.3d 1141
    , 1170.)
    Although ICJR correctly asserts that its profit figure of $1,430,260 was
    10    See footnote 6, ante.
    26
    uncontroverted, it does not necessarily follow that we can make a final
    determination that ICJR is entitled to recover this amount. The trial court
    possesses substantial discretion to balance the equities and fashion the
    award it deems appropriate. We will therefore remand so the court can
    conduct such further proceedings as it deems necessary to enable it to
    exercise its discretion in the first instance and determine the amount of
    profits to be disgorged from CHE and Sacaris.
    To guide the trial court upon remand, we note the following. First,
    while the court retains considerable discretion to determine the appropriate
    amount of an award of disgorgement, its discretion is not unfettered.
    “ ‘ “[T]he public policy of this state does not permit one to ‘take advantage of
    his own wrong’ ” regardless of whether the other party suffers actual
    damage.’ ” (Meister, supra, 230 Cal.App.4th at p. 398, quoting County of San
    Bernardino, supra, 158 Cal.App.4th at p. 542.) Disgorgement is meant, in
    part, to have a deterrent effect and ensure fiduciaries are held to a standard
    “ ‘stricter than the morals of the market place.’ ” (Feresi, supra, 232
    Cal.App.4th at p. 426.) The court’s statement of decision is a scathing
    indictment of years of misconduct by Sacaris and CHE. On this record,
    denying ICJR a recovery altogether would fail to recognize the seriousness of
    their wrongdoing and would fall short of achieving the goal of deterring
    future misconduct.
    Second, if the court, in the exercise of its discretion, wishes to consider
    reducing ICJR’s recovery by amounts it finds CHE and Sacaris can retain
    without being unjustly enriched, it is CHE and Sacaris, and not ICJR, who
    bear the burden to present evidence demonstrating the reasonableness of the
    amounts they charged ICJR for their management services. (Meister, supra,
    230 Cal.App.4th at p. 399.) The testimonial assertions of Sacaris and
    27
    Drozdova offered at trial regarding the reasonableness of CHE’s hourly rates
    failed to fully address this issue. The reasonableness of professional charges
    is more than a matter of hourly rates. Professional invoices can also be
    inflated by overstaffing and by billing an unreasonable number of hours,
    among other practices. (See generally State Bar of Cal., Com. on Mandatory
    Fee Arbitration, Arbitration Advisory 2016-02, Analysis of Potential Bill
    Padding and Other Billing Issues (Mar. 25, 2016).) Furthermore, because
    CHE and Sacaris are assigned the “residual risk of uncertainty” in the
    determination of profits subject to disgorgement (Uzyel, supra, 188
    Cal.App.4th at p. 894), any doubts as to the reasonableness of their charges
    must be resolved in favor of ICJR.
    B.    Pharmaceutical Symposia
    The trial court found CHE and Sacaris breached their fiduciary duties
    by failing to disclose to the board of ICJR that they were managing the
    pharmaceutical company symposia that took place during ICJR conferences
    and profiting by doing so, and by failing to obtain board approval for their
    engagement. However, the court concluded that running the symposia was
    not a corporate opportunity ICJR would have taken for itself, and that ICJR
    was therefore not harmed by, and could not recover for, the nondisclosures.
    On appeal, ICJR focuses on its purported right to recovery under the
    corporate opportunity doctrine. 11 ICJR disputes the court’s determination
    11    The fiduciary duty of full disclosure and fiduciary duty to avoid
    usurpation of corporate opportunities are distinct obligations. (See 3 Fletcher
    Cyc. Corp. (Sept. 2019) §§ 861.10 [Corporate opportunity doctrine], 837.70
    [Duty of full disclosure].) ICJR does not challenge whether, having found
    Sacaris and CHE responsible for breach of the fiduciary duty of disclosure,
    the court’s harm analysis should have focused on the harm that flowed from
    the nondisclosure, which is not necessarily identical to the harm created by
    ICJR’s loss of a corporate opportunity. (See Meister, supra, 
    230 Cal.App.4th 28
    that the symposia were not within ICJR’s line of business and argues the
    court ignored evidence that CHE used ICJR’s resources (including hotel
    conference rooms booked by ICJR and medical faculty enlisted by ICJR to
    lead conference seminars) to put on the symposia. Citing several out-of-state
    cases, ICJR contends this evidence compelled the conclusion that the
    symposia were an ICJR corporate opportunity that CHE and Sacaris
    wrongfully usurped.
    The corporate opportunity doctrine “prohibits one who occupies a
    fiduciary relationship to a corporation from acquiring, in opposition to the
    corporation, property in which the corporation has an interest or tangible
    expectancy or that is essential to its existence.” (3 Fletcher Cyc. Corp.
    (Sept. 2019) Corporate Opportunity Doctrine, § 861.10.) Whether or not a
    given corporate opportunity was wrongfully usurped is a question of fact to be
    determined from the facts and surrounding circumstances existing at the
    time the opportunity arises. (Kelegian v. Mgrdichian (1995) 
    33 Cal.App.4th 982
    , 989 [“California recognizes this [corporate opportunity] doctrine and also
    recognizes that whether or not a corporate opportunity exists is primarily a
    factual question”].) “ ‘Three tests have been recognized as standards for
    identifying a corporate opportunity: the “line of business” test, the “interest
    or expectancy” test, and the “fairness” test. Under any test, a corporate
    opportunity exists when a proposed activity is reasonably incident to the
    corporation’s present or prospective business and is one in which the
    corporation has the capacity to engage . . . . [Citation.]’ ” (Id. at p. 988.)
    at p. 401 [“[T]he remedy chosen by the trial court must be linked to a
    particular breach of fiduciary duty . . . .”].) Accordingly, we do not address
    this issue.
    29
    Substantial evidence supported the trial court’s determination that
    managing the pharmaceutical company symposia was not an ICJR corporate
    opportunity. The court reasoned there was no indication ICJR “would have
    been remotely interested” in producing the symposia and would have had to
    outsource management of the symposia to another event planning
    organization if not CHE. This reasoning was grounded in the trial evidence,
    including the testimony of Dr. Scott, who testified ICJR did not have the
    necessary personnel or expertise to plan or produce educational conferences
    without outside help. ICJR concedes as much, arguing it “was capable of
    engaging vendors to run its other symposia” and had “the capacity to do the
    same here.”
    Contrary to ICJR’s assertions, CHE’s use of ICJR resources to run the
    symposia did not, on its own, compel the conclusion the symposia were an
    ICJR business opportunity. The out-of-state cases on which ICJR relies
    stand for the proposition that a corporate fiduciary who uses corporate funds
    or other assets to develop a corporate opportunity will be estopped from
    arguing the corporation lacked sufficient money or resources to develop the
    opportunity. (Guth v. Loft (1939) 
    23 Del.Ch. 255
    ; Graham v. Mimms (1982)
    
    111 Ill.App.3d 751
    ; In re Trim-Lean Meat Products, Inc. (Bankr. Del. 1980) 
    4 B.R. 243
    , 247 (Trim-Lean).) These cases nevertheless adhere to the rule that
    “[t]he basic question in all cases is whether the director has appropriated
    something for himself that, in all fairness, should belong to the corporation.”
    (Trim-Lean, at p. 247.)
    ICJR’s argument and cited authorities fail to establish that the trial
    court erred. The court’s determination that the symposia did not present a
    business opportunity for ICJR was not based on its lack of available resources
    so much as its lack of demonstrated corporate ability or interest in planning
    30
    educational conferences for any companies, including itself. Estopping CHE
    and Sacaris from disputing whether ICJR had sufficient resources to run the
    symposia would not change the conclusion that the symposia were not a
    venture that “in all fairness, should belong to” ICJR. (Trim-Lean, 
    supra,
     4
    B.R. at p. 247.) 12
    Accordingly, the trial court did not err in determining that producing
    symposia for pharmaceutical companies was not an ICJR corporate
    opportunity.
    DISPOSITION
    The portion of the judgment finding in favor of CHE and Sacaris and
    against ICJR on ICJR’s cross-claim for breach of fiduciary duty (first cause of
    action), pertaining to amounts CHE and Sacaris billed for management
    services, is reversed. The matter is remanded to the trial court for further
    proceedings to determine the amount to be awarded to ICJR on this claim. In
    12    CHE’s unapproved use of ICJR’s assets was nevertheless potentially
    actionable. (See, e.g., 3 Fletcher Cyc. Corp. (Sept. 2019) § 1102 [“[D]irectors
    and other corporate officers are liable for misappropriation, diversion or
    conversion of corporate assets.”].) Here, however, the record does not reflect
    that ICJR pursued recovery of the purportedly misappropriated assets,
    except insofar as it claimed CHE’s use of such assets demonstrated the
    symposia were a corporate opportunity.
    31
    all other respects, the judgment is affirmed. Each side is to bear its own costs
    on appeal.
    McCONNELL, P. J.
    WE CONCUR:
    BENKE, J.
    IRION, J.
    32
    

Document Info

Docket Number: D076513

Filed Date: 11/30/2020

Precedential Status: Precedential

Modified Date: 11/30/2020